EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

OP2113, a new drug for chronic hypoxia‐induced pulmonary hypertension treatment in rat

Lukas Roubenne, Margaux Laisné, David Benoist, Marilyne Campagnac, Bénédicte Prunet, Philippe Pasdois, Guillaume Cardouat, Thomas Ducret, Jean-François Quignard, Pierre Vacher, Isabelle Baudrimont, Roger Marthan and 4 more

British Journal of Pharmacology · 2023-11 · 180 (21) · 2802-2821

DOI: 10.1111/bph.16174 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2023-07-25. Written by Lukas Roubenne and 15 co-authors. Institution: Univ. Bordeaux, INSERM, CRCTB, U 1045, F-33000, Bordeaux, France. Major MEDLINE topics: Hypertension, Pulmonary, Heart Failure, Ventricular Dysfunction, Right. Cited 9 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Pulmonary hypertension (PH) is a cardiovascular disease characterised by an increase in pulmonary arterial (PA) resistance leading to right ventricular (RV) failure. Reactive oxygen species (ROS) play a major role in PH. OP2113 is a drug with beneficial effects on cardiac injuries that targets mitochondrial ROS. The aim of the study was to address the in vivo therapeutic effect of OP2113 in PH. Experimental Approach PH was induced by 3 weeks of chronic hypoxia (CH‐PH) in rats treated with OP2113 or its vehicle via subcutaneous osmotic mini‐pumps. Haemodynamic parameters and both PA and heart remodelling were assessed. Reactivity was quantified in PA rings and in RV or left ventricular (LV) cardiomyocytes. Oxidative stress was detected by electron paramagnetic resonance and western blotting. Mitochondrial mass and respiration were measured by western blotting and oxygraphy, respectively. Key Results In CH‐PH rats, OP2113 reduced the mean PA pressure, PA remodelling, PA hyperreactivity in response to 5-HT , the contraction slowdown in RV and LV and increased the mitochondrial mass in RV. Interestingly, OP2113 had no effect on haemodynamic parameters, both PA and RV wall thickness and PA reactivity, in control rats. Whereas oxidative stress was evidenced by an increase in protein carbonylation in CH‐PH, this was not affected by OP2113. Conclusion and Implications Our study provides evidence for a selective protective effect of OP2113 in vivo on alterations in both PA and RV from CH‐PH rats without side effects in control rats.

Subjects

MeSH terms (MEDLINE)

Hypertension, PulmonaryHeart FailureVentricular Dysfunction, RightRatsAnimalsReactive Oxygen SpeciesHeart VentriclesPulmonary ArteryHypoxiaVentricular Function, RightDisease Models, Animal

Author keywords

oxidative stresspulmonary circulationpulmonary hypertensionright ventricle

Substances

Reactive Oxygen Species

Authors and institutions

  • Univ. Bordeaux, INSERM, CRCTB, U 1045, F-33000, Bordeaux, France.
  • OP2 Drugs SAS, Pessac, France.
  • Univ. Bordeaux, INSERM, CRCTB, U 1045, IHU Liryc, F-33000, Bordeaux, France.
  • CHU de Bordeaux, Service d'Explorations Fonctionnelles Respiratoires, INSERM, U 1045, Bordeaux, France.

Cite

APA

Roubenne, L., Laisné, M., Benoist, D., Campagnac, M., Prunet, B., Pasdois, P., Cardouat, G., Ducret, T., Quignard, J. F., Vacher, P., Baudrimont, I., Marthan, R., Berger, P., Le Grand, B., Freund-Michel, V., & Guibert, C. (2023). OP2113, a new drug for chronic hypoxia‐induced pulmonary hypertension treatment in rat. British Journal of Pharmacology, 180(21), 2802-2821. https://doi.org/10.1111/bph.16174

Vancouver

Roubenne L, Laisné M, Benoist D, Campagnac M, Prunet B, Pasdois P, et al. OP2113, a new drug for chronic hypoxia‐induced pulmonary hypertension treatment in rat. British Journal of Pharmacology. 2023;180(21):2802-2821. doi:10.1111/bph.16174

BibTeX
@article{Roubenne2023,
  author = {Roubenne, Lukas and Laisné, Margaux and Benoist, David and Campagnac, Marilyne and Prunet, Bénédicte and Pasdois, Philippe and Cardouat, Guillaume and Ducret, Thomas and Quignard, Jean-François and Vacher, Pierre and Baudrimont, Isabelle and Marthan, Roger and Berger, Patrick and Le Grand, Bruno and Freund-Michel, Véronique and Guibert, Christelle},
  title = {OP2113, a new drug for chronic hypoxia‐induced pulmonary hypertension treatment in rat},
  journal = {British Journal of Pharmacology},
  year = {2023},
  volume = {180},
  number = {21},
  pages = {2802--2821},
  doi = {10.1111/bph.16174}
}
Start for free →